Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06984263 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Sep 2028 to Oct 2028
    • Study completion date: Sep 2038 to Oct 2038
    • Start date changed from estimate of Sep 2025 to Oct 6, 2025
  2. Start date: May 2025 to Sep 2025
    • Enrollment target: 370 to 300
    • Primary completion date: May 2028 to Sep 2028
    • Study completion date: May 2038 to Sep 2038
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study aims to evaluate routine treatment outcomes in men with lichen sclerosus (LS), including a long-term follow-up to assess disease progression and histopathological changes. The study also investigates potential risk factors for LS and the disease's impact on quality of life and sexual health.
Trial Details
NCT Number NCT06984263
Lead Sponsor Region Västerbotten
Collaborators: Umeå University
Conditions
(from sponsor)		 Lichen Sclerosus
Related terms Lichen Sclerosus et Atrophicus
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov